Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Resverlogix Corp T.RVX

Alternate Symbol(s):  RVXCF

Resverlogix Corp. is a Canada-based late-stage biotechnology company. The Company is engaged in epigenetics, with a focus on developing therapies for the benefit of patients with chronic diseases. Its epigenetic therapies are designed to regulate the expression of disease-causing genes. The Company's clinical program is focused on evaluating its lead candidate apabetalone (RVX-208) for the treatment of cardiovascular disease and associated comorbidities, and post-COVID-19 conditions. RVX-208 is a small molecule that is a selective bromodomain and extra-terminal (BET) inhibitor. BET bromodomain inhibition is an epigenetic mechanism that can regulate disease-causing genes. RVX-208 is a BET inhibitor selective for the second bromodomain (BD2) within the BET proteins. It partners with EVERSANA, to support the commercialization of RVX-208 for cardiovascular disease, post-COVID-19 conditions, and pulmonary arterial hypertension in Canada and the United States.


TSX:RVX - Post by User

Post by general360on Apr 12, 2021 12:15pm
211 Views
Post# 32977694

volume sure died

volume sure died

after a "strong-for-rvx" open, we sure have hit the brick wall.  at this point there seem to be more trades for 1, 2, 4, 5 or 9 shares.  of the last 50 trades, all but about the last 10 are for piddly numbers.  painting the tape?  no real interest cause we're not saying how we're gonna pay for it...

where's the friggin beef CANADA or ALTA gov't?!?!?!  guess the market doesnt believe we'll
"Begin Immediate Clinical Studies of Apabetalone for COVID-19"

prolly interpreting it as a 2 month lead time to start...

again, more questions than answers....
<< Previous
Bullboard Posts
Next >>